SARTORIUS (SARTF)
(Delayed Data from OTC)
$248.00 USD
+0.97 (0.39%)
Updated Apr 26, 2024 12:23 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for SARTORIUS falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,675 | 4,398 | 4,081 | 2,668 | 1,613 |
Cost Of Goods | 1,979 | 2,084 | 1,905 | 1,291 | 775 |
Gross Profit | 1,696 | 2,314 | 2,176 | 1,377 | 838 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,151 | 1,192 | 1,107 | 856 | 466 |
Income After Depreciation & Amortization | 545 | 1,122 | 1,069 | 521 | 372 |
Non-Operating Income | 112 | 209 | 35 | 66 | 8 |
Interest Expense | 240 | 86 | 312 | 77 | 24 |
Pretax Income | 418 | 1,245 | 791 | 510 | 356 |
Income Taxes | 104 | 283 | 286 | 143 | 91 |
Minority Interest | 92 | 248 | 128 | 109 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 314 | 962 | 505 | 367 | 265 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 222 | 714 | 377 | 258 | 263 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 916 | 1,424 | 1,342 | 727 | 454 |
Depreciation & Amortization (Cash Flow) | 370 | 302 | 274 | 206 | 82 |
Income After Depreciation & Amortization | 545 | 1,122 | 1,069 | 521 | 372 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 68.63 | 68.43 | 68.43 | 68.57 | 92.18 |
Diluted EPS Before Non-Recurring Items | 5.35 | 10.09 | 9.56 | 4.99 | 3.19 |
Diluted Net EPS (GAAP) | 3.24 | 10.44 | 5.51 | 3.78 | 2.84 |
Fiscal Year end for SARTORIUS falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 916.09 | 882.37 | 907.21 | 969.49 |
Cost Of Goods | NA | 559.06 | 490.65 | 463.53 | 465.86 |
Gross Profit | NA | 357.03 | 391.72 | 443.68 | 503.64 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 226.96 | 304.65 | 306.94 | 312.14 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 130.07 | 87.07 | 136.74 | 191.50 |
Non-Operating Income | NA | 25.40 | -23.40 | 89.30 | 21.15 |
Interest Expense | NA | 111.02 | 39.73 | 55.17 | 34.13 |
Pretax Income | NA | 44.34 | 23.94 | 170.87 | 178.51 |
Income Taxes | NA | 22.22 | 6.42 | 28.57 | 46.59 |
Minority Interest | NA | 13.03 | 8.05 | 38.71 | 32.09 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 22.02 | 17.52 | 142.30 | 132.03 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 8.99 | 9.47 | 103.59 | 99.93 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 70.00 | 66.15 | 68.35 | 68.46 |
Diluted EPS Before Non-Recurring Items | NA | 1.01 | 1.13 | 1.37 | 1.81 |
Diluted Net EPS (GAAP) | NA | 0.12 | 0.14 | 1.52 | 1.46 |